Imricor Medical Systems, Inc. · ASX:IMR
Imricor Medical Systems — Shareholder Meeting (May 2024)
8 slides from Imricor Medical Systems's shareholder meeting presentation, May 2024
Slide 1: Annual General Meeting May 2024
rsonal use only Annual General Meeting May 2024 IMRICOR MEDICAL SYSTEMS, INC (ASX:IMR) WWW.IMRICOR.COM
Slide 2: Disclaimer
Disclaimer The material contained in this presentation is intended to be general background those which we expect, depending on the outcome of various factors. Investors and others information on Imricor Medical Systems, Inc. (Imricor) and its activities. are cautioned not to place undue reliance on
Slide 3: Imricor's Board of Directors and CFO
Imricor’s Board of Directors and CFO rsonal use only Steve Wedan Mark Tibbles Anita Messal Peter McGregor Jonathon Gut Executive Chair, Deputy Chair, Non-Executive Director Non-Executive Director CFO President, & CEO Non-Executive Director 2024 AGM | 3
Slide 4: Chair's Address
rsonal use only Chair’s Address
Slide 5: Clinician quote on NorthStar in the iCMR
rsonal use only "What may have taken several hours in the x-ray lab took less than an hour to perform using NorthStar in the iCMR." Dr. Marco Götte - Amsterdam UMC, April 2024
Slide 6: Priorities for 2024
Priorities for 2024 Clinical Trials rsonal use only • Execute VISABL-AFL global trial to support FDA approval in the US • Execute VISABL-VT trial to support expanded indications for ablation catheter in Europe Commercial Momentum • Consistent procedure volume at active sites • Steady activation of n
Slide 7: Imricor Leadership Team
Imricor Leadership Team Management Board of Directors rsonal use only Steve Wedan Jonathon Gut Gregg Stenzel Jennifer Weisz Nick Twohy Steve Wedan Mark Tibbles President and Chief Vice President of Chief Operating Vice President of Vice President of President and Chief Deputy Chair and Lead Executiv
Slide 8: Contact Information
Contact Information rsonal use only Investors & Australian Media: Simon Hinsley NWR Communications [email protected] +61 401 809 653 Investors: Steve Wedan Executive Chair, President & CEO [email protected] Nick Corkill Vice President, Corporate Strategy [email protected] +
Imricor Medical Systems — Shareholder Meeting (May 2024) on 6ix